Based on the data, the number of patents in the biotechnology sector in Denmark fluctuated over the past years, with notable variations: a decline in 2015, stabilization in 2016, followed by growth in 2017. However, declines were seen again in 2018 and 2019, returning to modest increases from 2020 onwards. Standing at 178.3 units in 2023, the sector has shown a growth trajectory. In the last two years, the year-on-year variations were average, and the last 5 CAGR stood at 0.35%, showing a volatile but gradually positive trend.

The forecast from 2024 to 2028 predicts steady growth with a forecasted 5-year CAGR of 0.68% and a cumulative growth rate of 3.45%. This implies a slowly improving innovation environment in the Danish biotechnology sector.

Future trends to watch for include:

Emergence of new biotechnological innovations and breakthroughs influencing patent numbers.
Policies and funding trends in Denmark that could impact R&D activities.
Global biotech market trends and Denmark’s participation in international collaborations.
Impact of external factors like regulatory changes and economic conditions on patent activities.